Complimentary CME/CE programs on the newest, evidence-based
measures to prevent cardiovascular disease.
Complimentary CME/CE presentations delivered
by American Heart Association experts at hospital grand rounds, nationwide.
Heart disease is the number one killer of men and women in the United States, and nearly 70% of the population, over 60 years of age, are personally affected by cardiovascular disease. Educating healthcare professionals on the latest science, and current guideline recommendations can help to improve patient care and promote better outcomes.
The American Heart Association promises to be the most trusted provider of quality and relevant professional education by delivering best practice and emerging scientific knowledge to healthcare professionals and resources to translate that knowledge for the prevention, diagnosis and treatment of cardiovascular disease and stroke.
Spotlight Series, which began in 2008, offers free, case-based presentations designed to educate healthcare providers on evidence-based practices. The target audience includes internists, family practice physicians and other primary care physicians, cardiologists, nurses, pharmacists, physician assistants and other clinicians involved in the treatment of patients with or at risk for cardiovascular disease. The AHA is the accredited provider for this program and CME/CE credit is available to all physician, nurse and pharmacist attendees.
By incorporating Spotlight Series presentations into your institution's educational programming, together we can help build healthier lives, free of cardiovascular diseases and stroke.
IT'S FREE! There is no cost to your institution.
By AHA Experts
Did we mention IT'S FREE?
Please select a series below to view more information
African Americans are significantly more likely than whites to be diagnosed with hypertension, yet are significantly less likely to achieve blood pressure goals despite equal or even higher levels of treatment. . For more information please visit Racial and Ethnic Disparities in Hypertension
This activity is supported by an independent medical educational grant from Novartis Pharmaceuticals.
Anticoagulation is an important consideration in the management of atrial fibrillation. The goal of this accredited education program will be stroke prevention in atrial fibrillation including factors contributing to stroke risk, bleeding risk in AF patients and issues related to appropriate anticoagulants. Please click here for more information.
This activity is supported by independent medical educational grants from the Bristol-Myers Squibb/Pfizer Pharmaceuticals Partnership and Boehringer Ingelheim Pharmaceuticals, Inc.
Your feedback is important to us. For all inquiries, comments, and suggestions regarding the Spotlight Series, please complete the form below.